BioMarin Pharmaceutical Inc. buy Wolfe Research
Start price
15.07.25
/
50%
€49.93
Target price
15.07.26
€81.42
Performance (%)
-8.03%
Price
16.04.26
€45.92
Summary
This prediction is currently active. With a performance of -8.03%, the BUY prediction by Wolfe_Research is trending in the wrong direction. This prediction currently runs until 15.07.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -4.486% | -4.486% |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by Wolfe_Research for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was given a new $95.00 price target on by analysts at Wolfe Research. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.46
16.03.26
16.03.26
-
16.03.27
16.03.27
-9.00%
16.04.26
16.04.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€60.78
15.11.24
15.11.24
€89.95
15.11.25
15.11.25
-22.26%
16.11.25
16.11.25